Aish Sinha
@AishSinha1
Cardiology Registrar, NIHR academic clinical lecturer interested in coronary physiology
➡️ Among patients with EF <30%, those with more scar have significantly worse outcomes ➡️ Even in those with slightly better EF (30-40), we can identify those at higher risk by looking at the volume and pattern of their scar
The INOCA 2025 programme is now live! Get ready for expert insights, practical demonstrations, and lively debate, including sessions such as: ⏳ Coronary Microvascular Dysfunction: The Evolution from Syndrome X 💧 How to Do Bolus Thermodilution 🧭 BHF/NIHR UK CMD Workstream…
Unravelling the contributions of ischaemia and scar in arrhythmogenesis - these two papers give us the answers!⚡️🫀 Ischaemia paper 🔗 pubmed.ncbi.nlm.nih.gov/39661477/ @divaka_perera @achir76 @sohaibnazir @webmd11 @drjohnm @LambiasePier @SVRaoMD @aayshacader @DrMarthaGulati @TCTMD_Yael
🚨@REVIVED_BCIS2 scar analysis🫀 ➡️Scar volume & pattern highly associated with death and arrhythmia ➡️Scar assessment should be routine, particularly in those at borderline risk Out now @JACCJournals CVI🔗 jacc.org/doi/10.1016/j.… 📺Watch our summary👇 youtu.be/-eMrPRPToM0
🚨@REVIVED_BCIS2 scar analysis🫀 ➡️Scar volume & pattern highly associated with death and arrhythmia ➡️Scar assessment should be routine, particularly in those at borderline risk Out now @JACCJournals CVI🔗 jacc.org/doi/10.1016/j.… 📺Watch our summary👇 youtu.be/-eMrPRPToM0
ICYMI: Registration is open for #INOCA2025, bringing together clinicians, researchers, patients and industry experts to share insights and foster collaboration💚 🗓️25-26 Sept | 📍London Institute for Healthcare Engineering 🔍An in-depth look at coronary microvascular…
@divaka_perera shares insights from the SERIAL study: 1st randomized comparison of #FFR & #iFR in serial CAD 📺 youtu.be/M3CGzreHwlI 🔗jacc.org/doi/10.1016/j.… @mattlkw @UKHeartResearch @JACCJournals #JACCINT #ACCFIT
What better way to launch our @YouTube channel youtube.com/@ukheartresear… than with a brilliant summary of the SERIAL trial by @mattlkw! youtu.be/xqCdxL-pUiQ?fe…
This first randomized comparison of FFR & iFR in serial #cvCAD shows that both FFR & iFR pullbacks overestimate hemodynamic benefits of #PCI. Post-PCI physiology should be routinely performed in diffuse & serial disease. jacc.org/doi/10.1016/j.… @divaka_perera @mattlkw #JACCINT
Great work @mattlkw and the SERIAL Trial group! 1️⃣ pre-PCI #pullback is essential (can change treatment strategy and target lesion) 2️⃣ BUT we tend to overestimate the effect of PCI/underestimate impact of non-target disease by FFR or iFR 3️⃣ must check post-PCI FFR+pullback
🚨FFR and iFR systematically overestimate the result of PCI in serial and diffuse coronary disease 🚨 #CoronaryPhysiology 🎲Randomised 👁️Blinded 🙋♀️Within patient comparison 🔗 Full link @JACCJournals jacc.org/doi/10.1016/j.… 📺Watch our summary below👇
🚨FFR and iFR systematically overestimate the result of PCI in serial and diffuse coronary disease 🚨 #CoronaryPhysiology 🎲Randomised 👁️Blinded 🙋♀️Within patient comparison 🔗 Full link @JACCJournals jacc.org/doi/10.1016/j.… 📺Watch our summary below👇
🔥 A third of places for #INOCA2025 are already gone! 🗓️ 25–26 Sept | 📍 London ✅ Live cases ✅ Patient stories ✅ Tech & trials ✅ Real-world clinical tools Don't miss this key event on Coronary Microvascular Dysfunction: millbrook-events.co.uk/INOCA2025
Registration is OPEN for #INOCA2025! 🗓️ 25–26 Sept | 📍 London Join @divaka_perera and @achir76, for two days of cutting-edge insights into Coronary Microvascular Dysfunction. ✅ Live cases ✅ Patient stories ✅ Tech & trials ✅ Real-world clinical tools Register here:…
Going to be a brilliant CMD and vasospasm couple of days with live cases and world class talks. Can't wait.
Registration is OPEN for #INOCA2025! 🗓️ 25–26 Sept | 📍 London Join @divaka_perera and @achir76, for two days of cutting-edge insights into Coronary Microvascular Dysfunction. ✅ Live cases ✅ Patient stories ✅ Tech & trials ✅ Real-world clinical tools Register here:…
Registration is OPEN for #INOCA2025! 🗓️ 25–26 Sept | 📍 London Join @divaka_perera and @achir76, for two days of cutting-edge insights into Coronary Microvascular Dysfunction. ✅ Live cases ✅ Patient stories ✅ Tech & trials ✅ Real-world clinical tools Register here:…
Everything you wanted to know about INOCA in 2 days! Well worth registering asap for #INOCA2025, a @TheBHF - @NIHRresearch CV partnership meeting. Stellar international faculty, guideline updates, how to sessions, debates, breaking research, discussion, live cases and more!
Registration is OPEN for #INOCA2025! 🗓️ 25–26 Sept | 📍 London Join @divaka_perera and @achir76, for two days of cutting-edge insights into Coronary Microvascular Dysfunction. ✅ Live cases ✅ Patient stories ✅ Tech & trials ✅ Real-world clinical tools Register here:…
A clear and concise lay summary by @TheBHF on the impact of the LMCA Physiology study👏 🔗Manuscript: ahajournals.org/doi/10.1161/CI… - @CircIntv @SVRaoMD 🔗Editorial: ahajournals.org/doi/10.1161/CI… - @wfearonmd 🔗BHF 📰: bhf.org.uk/what-we-do/new… @kingsmedicine @kingscardio @Kings_BHFCentre
Congrats to our @Kings_BHFCentre colleague Prof Divaka Perera who completed the London to Brighton Bike Ride yesterday to raise money for @TheBHF Divaka has blown past his target of £1,350, but there's still time to donate! Consider giving here: justgiving.com/team/cardiaccy…
Medical therapy and outcomes in REVIVED-BCIS2 and STICHES. Read this individual patient data analysis published in #EHJ academic.oup.com/eurheartj/arti… @escardio @ESC_Journals #heartfailure #revascularization #PCI